Mount Yale Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1M Buy
94,655
+34,118
+56% +$7.95M 0.54% 43
2025
Q4
$12.5M Buy
60,537
+18,260
+43% +$3.61M 0.6% 35
2025
Q3
$7.84M Buy
42,277
+26,567
+169% +$4.55M 0.55% 38
2025
Q2
$2.4M Sell
15,710
-1,446
-8% -$222K 0.19% 110
2025
Q1
$2.85M Sell
17,156
-1,216
-7% -$190K 0.24% 89
2024
Q4
$2.66M Sell
18,372
-52
-0.3% -$8.06K 0.21% 95
2024
Q3
$2.99M Sell
18,424
-3,723
-17% -$593K 0.29% 81
2024
Q2
$3.24M Buy
22,147
+96
+0.4% +$14.3K 0.26% 79
2024
Q1
$3.49M Buy
22,051
+1,033
+5% +$164K 0.27% 79
2023
Q4
$3.29M Sell
21,018
-637
-3% -$97.7K 0.31% 79
2023
Q3
$3.37M Sell
21,655
-5,544
-20% -$915K 0.37% 63
2023
Q2
$4.5M Sell
27,199
-906
-3% -$146K 0.48% 43
2023
Q1
$4.36M Buy
28,105
+1,000
+4% +$161K 0.49% 44
2022
Q4
$4.79M Buy
27,105
+900
+3% +$155K 0.54% 47
2022
Q3
$4.28M Sell
26,205
-182
-0.7% -$30.8K 0.57% 39
2022
Q2
$4.68M Buy
26,387
+920
+4% +$164K 0.59% 37
2022
Q1
$4.51M Buy
25,467
+1,742
+7% +$296K 0.49% 48
2021
Q4
$4.06M Buy
23,725
+1,120
+5% +$183K 0.42% 52
2021
Q3
$3.65M Buy
22,605
+5,132
+29% +$876K 0.42% 58
2021
Q2
$2.88M Buy
17,473
+1,393
+9% +$231K 0.35% 72
2021
Q1
$2.64M Buy
16,080
+275
+2% +$44.5K 0.34% 73
2020
Q4
$2.49M Buy
15,805
+287
+2% +$42.4K 0.35% 74
2020
Q3
$2.31M Buy
15,518
+2,315
+18% +$343K 0.33% 74
2020
Q2
$1.86M Buy
13,203
+2,210
+20% +$322K 0.33% 75
2020
Q1
$1.44M Buy
10,993
+3,354
+44% +$476K 0.33% 75
2019
Q4
$1.14M Sell
7,639
-282
-4% -$38.2K 0.2% 115
2019
Q3
$1.04M Buy
7,921
+235
+3% +$31K 0.19% 114
2019
Q2
$1M Sell
7,686
-519
-6% -$71.8K 0.18% 112
2019
Q1
$1.15M Sell
8,205
-3,387
-29% -$454K 0.21% 105
2018
Q4
$1.53M Sell
11,592
-1,631
-12% -$228K 0.31% 82
2018
Q3
$1.91M Buy
13,223
+247
+2% +$32.8K 0.33% 69
2018
Q2
$1.57M Buy
12,976
+752
+6% +$93.8K 0.3% 84
2018
Q1
$1.57M Buy
+12,224
New +$1.65M 0.34% 79

Other funds holding JNJ

Mount Yale Investment Advisors's JNJ Position: Q1 2026 in Review

Mount Yale Investment Advisors increased its Johnson & Johnson (JNJ) stake by 56% in Q1 2026, buying an estimated $7.95M and bringing the position to 94,655 shares worth $23.1M. The position accounts for 0.54% of the portfolio, ranked #43.

Mount Yale Investment Advisors first reported a position in JNJ in Q1 2018 and has held it in 33 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mount Yale Investment Advisors held 94,655 shares of Johnson & Johnson worth $23.1M as of Q1 2026.
  • Mount Yale Investment Advisors bought 34,118 Johnson & Johnson shares in Q1 2026, an estimated $7.95M.
  • Johnson & Johnson made up 0.54% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #43 holding.
  • Mount Yale Investment Advisors first reported a position in Johnson & Johnson in Q1 2018 and has held it in 33 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.